H. R. 6—237 
that enables consideration of whether the national 
media campaign has contributed to changes in atti-
tude or behaviors among the target audience with 
respect to substance use and such other measures 
of evaluation as the Director determines are appro-
priate. 
‘‘(3) ADVERTISING.—In carrying out this subsection, the 
Director shall ensure that sufficient funds are allocated to 
meet the stated goals of the national media campaign. 
‘‘(4) RESPONSIBILITIES
AND
FUNCTIONS
UNDER
THE
PRO-
GRAM.— 
‘‘(A) IN GENERAL.—The Director shall determine the 
overall purposes and strategy of the national media cam-
paign. 
‘‘(B) DIRECTOR.— 
‘‘(i) IN GENERAL.—The Director shall approve— 
‘‘(I) the strategy of the national media cam-
paign; 
‘‘(II) all advertising and promotional material 
used in the national media campaign; and 
‘‘(III) the plan for the purchase of advertising 
time and space for the national media campaign. 
‘‘(ii) IMPLEMENTATION.—The Director shall be 
responsible for implementing a focused national media 
campaign to meet the purposes set forth in paragraph 
(1) and shall ensure— 
‘‘(I) information disseminated through the 
campaign is accurate and scientifically valid; and 
‘‘(II) the campaign is designed using strategies 
demonstrated to be the most effective at achieving 
the goals and requirements of paragraph (1), which 
may include— 
‘‘(aa) a media campaign, as described in 
paragraph (2); 
‘‘(bb) local, regional, or population specific 
messaging; 
‘‘(cc) the development of websites to pub-
licize and disseminate information; 
‘‘(dd) conducting outreach and providing 
educational resources for parents; 
‘‘(ee) collaborating with law enforcement 
agencies; and 
‘‘(ff) providing support for school-based 
public health education classes to improve teen 
knowledge about the effects of substance use. 
‘‘(5) PROHIBITIONS.—None of the amounts made available 
under paragraph (2) may be obligated or expended for any 
of the following: 
‘‘(A) To supplant current anti-drug community-based 
coalitions. 
‘‘(B) To supplant pro bono public service time donated 
by national and local broadcasting networks for other public 
service campaigns. 
‘‘(C) For partisan political purposes, or to express 
advocacy in support of or to defeat any clearly identified 
candidate, clearly identified ballot initiative, or clearly 
identified legislative or regulatory proposal.
H. R. 6—238 
‘‘(D) To fund advertising that features any elected offi-
cials, persons seeking elected office, cabinet level officials, 
or other Federal officials employed pursuant to section 
213 of Schedule C of title 5, Code of Federal Regulations. 
‘‘(E) To fund advertising that does not contain a pri-
mary message intended to reduce or prevent substance 
use. 
‘‘(F) To fund advertising containing a primary message 
intended to promote support for the national media cam-
paign or private sector contributions to the national media 
campaign. 
‘‘(6) MATCHING REQUIREMENT.— 
‘‘(A) IN
GENERAL.—Amounts made available under 
paragraph (2) for media time and space shall be matched 
by an equal amount of non-Federal funds for the national 
media campaign, or be matched with in-kind contributions 
of the same value. 
‘‘(B) NO-COST MATCH ADVERTISING DIRECT RELATION-
SHIP REQUIREMENT.—The Director shall ensure that not 
less than 85 percent of no-cost match advertising directly 
relates to substance abuse prevention consistent with the 
specific purposes of the national media campaign. 
‘‘(C) NO-COST
MATCH
ADVERTISING
NOT
DIRECTLY 
RELATED.—The Director shall ensure that no-cost match 
advertising that does not directly relate to substance abuse 
prevention consistent with the purposes of the national 
media campaign includes a clear anti-drug message. Such 
message is not required to be the primary message of 
the match advertising. 
‘‘(7) FINANCIAL AND PERFORMANCE ACCOUNTABILITY.—The 
Director shall cause to be performed— 
‘‘(A) audits and reviews of costs of the national media 
campaign pursuant to section 4706 of title 41, United States 
Code; and 
‘‘(B) an audit to determine whether the costs of the 
national media campaign are allowable under chapter 43 
of title 41, United States Code. 
‘‘(8) REPORT TO CONGRESS.—The Director shall submit on 
an annual basis a report to Congress that describes— 
‘‘(A) the strategy of the national media campaign and 
whether specific objectives of the national media campaign 
were accomplished; 
‘‘(B) steps taken to ensure that the national media 
campaign operates in an effective and efficient manner 
consistent with the overall strategy and focus of the 
national media campaign; 
‘‘(C) plans to purchase advertising time and space; 
‘‘(D) policies and practices implemented to ensure that 
Federal funds are used responsibly to purchase advertising 
time and space and eliminate the potential for waste, fraud, 
and abuse; 
‘‘(E) all contracts entered into with a corporation, part-
nership, or individual working on behalf of the national 
media campaign; 
‘‘(F) the results of any financial audit of the national 
media campaign;
H. R. 6—239 
‘‘(G) a description of any evidence used to develop 
the national media campaign; 
‘‘(H) specific policies and steps implemented to ensure 
compliance with this section; 
‘‘(I) a detailed accounting of the amount of funds obli-
gated during the previous fiscal year for carrying out the 
national media campaign, including each recipient of funds, 
the purpose of each expenditure, the amount of each 
expenditure, any available outcome information, and any 
other information necessary to provide a complete 
accounting of the funds expended; and 
‘‘(J) a review and evaluation of the effectiveness of 
the national media campaign strategy for the past year. 
‘‘(9) REQUIRED
NOTICE
FOR
COMMUNICATION
FROM
THE 
OFFICE.—Any communication, including an advertisement, paid 
for or otherwise disseminated by the Office directly or through 
a contract awarded by the Office shall include a prominent 
notice informing the audience that the communication was 
paid for by the Office. 
‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Office to carry out this section, $25,000,000 
for each of fiscal years 2018 through 2023.’’. 
(b) TECHNICAL AND CONFORMING AMENDMENT.—Subsection (a) 
of section 203 of the Office of National Drug Control Policy 
Reauthorization Act of 2006 (21 U.S.C. 1708a) is repealed. 
SEC. 8219. DRUG INTERDICTION. 
(a) REPEAL.—This first section 711 of the Office of National 
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1710) 
is repealed. 
(b) AMENDMENTS.—Section 711 of the Office of National Drug 
Control Policy Reauthorization Act of 1998 (21 U.S.C. 1710), as 
added by Public Law 109–469 (120 Stat. 3507), is amended— 
(1) in subsection (a)— 
(A) in paragraph (1)— 
(i) by striking ‘‘The United’’ and inserting ‘‘The 
Director shall designate or appoint an appointee in 
the Senior Executive Service or an appointee in a 
position at level 15 of the General Schedule (or equiva-
lent) as the United’’; and 
(ii) by striking ‘‘shall’’ and inserting ‘‘to’’; 
(B) in paragraph (2)(B)— 
(i) by striking ‘‘March 1’’ and inserting ‘‘September 
1’’; and 
(ii) by striking ‘‘paragraph (3)’’ and inserting ‘‘para-
graph (4)’’; 
(C) in paragraph (3)— 
(i) by striking ‘‘also, at his discretion,’’; and 
(ii) by striking ‘‘the Office of Supply Reduction 
for that purpose’’ and inserting ‘‘assist in carrying out 
such responsibilities’’; and 
(D) in paragraph (4)— 
(i) in subparagraph (B), by striking ‘‘The United’’ 
and inserting ‘‘Before submission of the National Drug 
Control Strategy or annual assessment required under 
section 706, as applicable, the United’’; 
(ii) by striking subparagraphs (C) and (E);
H. R. 6—240 
(iii) by redesignating subparagraph (D) as subpara-
graph (C); 
(iv) in subparagraph (C), as so redesignated— 
(I) in the matter preceding clause (i)— 
(aa) by striking ‘‘March 1’’ and inserting 
‘‘September 1’’; 
(bb) by inserting ‘‘the Director, acting 
through’’ before ‘‘the United States’’; 
(cc) by inserting a comma after ‘‘Coordi-
nator’’; 
(dd) by striking ‘‘a report on behalf of 
the Director’’; and 
(ee) by striking ‘‘, which shall include’’ 
and inserting ‘‘a report that’’; 
(II) by redesignating clauses (i), (ii), and (iii) 
as subclauses (I), (II), and (III), and adjusting the 
margins accordingly; 
(III) by inserting before subclause (I), as so 
redesignated, the following: 
‘‘(i) includes—’’; 
(IV) in clause (i), as so redesignated— 
(aa) in subclause (I), as so redesignated, 
by inserting ‘‘, including information about 
how each National Drug Control Program 
agency conducting drug interdiction activities 
is engaging with relevant international part-
ners’’ after ‘‘Plan’’; 
(bb) in subclause (II), as so redesignated, 
by striking ‘‘, as well as’’ and inserting ‘‘and’’; 
(cc) in subclause III, as so redesignated— 
(AA) by striking ‘‘, as well as’’ and 
inserting ‘‘and’’; and 
(BB) by striking the period at the end 
and inserting ‘‘; and’’; and 
(V) by adding at the end the following: 
‘‘(ii) may include recommendations for changes to 
existing agency authorities or laws governing inter-
agency relationships.’’; and 
(v) by adding at the end the following: 
‘‘(D) CLASSIFIED ANNEX.—Each report required to be 
submitted under subparagraph (C) shall be in unclassified 
form, but may include a classified annex.’’; 
(2) in subsection (b)— 
(A) in paragraph (1)(B), by inserting ‘‘and how to 
strengthen international partnerships to better achieve the 
goals of that plan’’ after ‘‘that plan’’; 
(B) in paragraph (2)— 
(i) in the paragraph heading, by striking ‘‘CHAIR-
MAN’’ and inserting ‘‘CHAIRPERSON’’; and 
(ii) by striking ‘‘chairman’’ and inserting ‘‘Chair-
person’’; 
(C) in paragraph (3)— 
(i) by striking ‘‘prior to March 1’’ and inserting 
‘‘before June 1’’; 
(ii) by striking ‘‘either’’ each place it appears; 
(iii) by striking ‘‘current chairman’’ and inserting 
‘‘Chairperson’’; and
H. R. 6—241 
(iv) by striking ‘‘they’’ and inserting ‘‘the mem-
bers’’; and 
(D) in paragraph (4)— 
(i) by striking ‘‘chairman’’ each place it appears 
and inserting ‘‘Chairperson’’; 
(ii) in the first sentence, by striking ‘‘a report’’; 
(iii) by inserting ‘‘a report’’ after ‘‘committees’’; and 
(iv) by striking the second sentence and inserting 
the following: ‘‘The report required under this para-
graph shall be in unclassified form, but may include 
a classified annex.’’; and 
(3) by adding at the end the following: 
‘‘(c) INTERNATIONAL COORDINATION.—The Director may facili-
tate international drug control coordination efforts.’’. 
SEC. 8220. GAO AUDIT. 
Not later than 4 years after the date of enactment of this 
Act, and every 4 years thereafter, the Comptroller General of the 
United States shall— 
(1) conduct an audit relating to the programs and oper-
ations of— 
(A) the Office; and 
(B) certain programs within the Office, including— 
(i) the High Intensity Drug Trafficking Areas Pro-
gram; 
(ii) the Drug-Free Communities Program; and 
(iii) the campaign under section 709(f) of the Office 
of National Drug Control Policy Reauthorization Act 
of 1998 (21 U.S.C. 1708(f)); and 
(2) submit to the Director and the appropriate congressional 
committees a report containing an evaluation of and rec-
ommendations on the— 
(A) policies and activities of the programs and oper-
ations subject to the audit; 
(B) economy, efficiency, and effectiveness in the 
administration of the reviewed programs and operations; 
and 
(C) policy or management changes needed to prevent 
and detect fraud and abuse in such programs and oper-
ations. 
SEC. 8221. NATIONAL DRUG CONTROL STRATEGY. 
(a) IN GENERAL.—Section 706 of the Office of National Drug 
Control Policy Reauthorization Act of 1998 (21 U.S.C. 1705) is 
amended to read as follows: 
‘‘SEC. 706. NATIONAL DRUG CONTROL STRATEGY. 
‘‘(a) IN GENERAL.— 
‘‘(1) STATEMENT OF DRUG POLICY PRIORITIES.—The Director 
shall release a statement of drug control policy priorities in 
the calendar year of a Presidential inauguration following the 
inauguration, but not later than April 1. 
‘‘(2) NATIONAL DRUG CONTROL STRATEGY SUBMITTED BY THE 
PRESIDENT.—Not later than the first Monday in February fol-
lowing the year in which the term of the President commences, 
and every 2 years thereafter, the President shall submit to 
Congress a National Drug Control Strategy.
H. R. 6—242 
‘‘(b) 
DEVELOPMENT
OF
THE
NATIONAL
DRUG
CONTROL 
STRATEGY.— 
‘‘(1) PROMULGATION.—The Director shall promulgate the 
National Drug Control Strategy, which shall set forth a com-
prehensive plan to reduce illicit drug use and the consequences 
of such illicit drug use in the United States by limiting the 
availability of and reducing the demand for illegal drugs and 
promoting prevention, early intervention, treatment, and 
recovery support for individuals with substance use disorders. 
‘‘(2) STATE AND LOCAL COMMITMENT.—The Director shall 
seek the support and commitment of State, local, and Tribal 
officials in the formulation and implementation of the National 
Drug Control Strategy. 
‘‘(3) STRATEGY
BASED
ON
EVIDENCE.—The Director shall 
ensure the National Drug Control Strategy is based on the 
best available evidence regarding the policies that are most 
effective in reducing the demand for and supply of illegal drugs. 
‘‘(4) PROCESS
FOR
DEVELOPMENT
AND
SUBMISSION
OF 
NATIONAL DRUG CONTROL STRATEGY.—In developing and effec-
tively implementing the National Drug Control Strategy, the 
Director— 
‘‘(A) shall consult with— 
‘‘(i) the heads of the National Drug Control Pro-
gram Agencies; 
‘‘(ii) each Coordinator listed in section 704; 
‘‘(iii) the Interdiction Committee and the Emerging 
Threats Committee; 
‘‘(iv) the appropriate congressional committees and 
any other committee of jurisdiction; 
‘‘(v) State, local, and Tribal officials; 
‘‘(vi) private citizens and organizations, including 
community and faith-based organizations, with experi-
ence and expertise in demand reduction; 
‘‘(vii) private citizens and organizations with 
experience and expertise in supply reduction; and 
‘‘(viii) 
appropriate 
representatives 
of 
foreign 
governments; and 
‘‘(B) in satisfying the requirements of subparagraph 
(A), shall ensure, to the maximum extent possible, that 
State, local, and Tribal officials and relevant private 
organizations commit to support and take steps to achieve 
the goals and objectives of the National Drug Control 
Strategy. 
‘‘(c) CONTENTS OF THE NATIONAL DRUG CONTROL STRATEGY.— 
‘‘(1) IN GENERAL.—The National Drug Control Strategy sub-
mitted under subsection (a)(2) shall include the following: 
‘‘(A) A mission statement detailing the major functions 
of the National Drug Control Program. 
‘‘(B) Comprehensive, research-based, long-range, quan-
tifiable goals for reducing illicit drug use, and the con-
sequences of illicit drug use in the United States. 
‘‘(C) Annual quantifiable and measurable objectives 
and specific targets to accomplish long-term quantifiable 
goals that the Director determines may be achieved during 
each year beginning on the date on which the National 
Drug Control Strategy is submitted.
H. R. 6—243 
‘‘(D) A 5-year projection for the National Drug Control 
Program and budget priorities. 
‘‘(E) A review of international, State, local, and private 
sector drug control activities to ensure that the United 
States pursues coordinated and effective drug control at 
all levels of government. 
‘‘(F) A description of how each goal established under 
subparagraph (B) will be achieved, including for each goal— 
‘‘(i) a list of each relevant National Drug Control 
Program Agency and each such agency’s related pro-
grams, activities, and available assets and the role 
of each such program, activity, and asset in achieving 
such goal; 
‘‘(ii) a list of relevant stakeholders and each such 
stakeholder’s role in achieving such goal; 
‘‘(iii) an estimate of Federal funding and other 
resources needed to achieve such goal; 
‘‘(iv) a list of each existing or new coordinating 
mechanism needed to achieve such goal; and 
‘‘(v) a description of the Office’s role in facilitating 
the achievement of such goal. 
‘‘(G) For each year covered by the Strategy, a perform-
ance evaluation plan for each goal established under 
subparagraph (B) for each National Drug Control Program 
Agency, including— 
‘‘(i) 
specific 
performance 
measures 
for 
each 
National Drug Control Program Agency; 
‘‘(ii) annual and, to the extent practicable, quar-
terly objectives and targets for each performance 
measure; and 
‘‘(iii) an estimate of Federal funding and other 
resources needed to achieve each performance objective 
and target. 
‘‘(H) A list identifying existing data sources or a 
description of data collection needed to evaluate perform-
ance, including a description of how the Director will obtain 
such data. 
‘‘(I) A list of any anticipated challenges to achieving 
the National Drug Control Strategy goals and planned 
actions to address such challenges. 
‘‘(J) A description of how each goal established under 
subparagraph (B) was determined, including— 
‘‘(i) a description of each required consultation and 
a description of how such consultation was incor-
porated; and 
‘‘(ii) data, research, or other information used to 
inform the determination to establish the goal. 
‘‘(K) A description of the current prevalence of illicit 
drug use in the United States, including both the avail-
ability of illicit drugs and the prevalence of substance use 
disorders. 
‘‘(L) Such other statistical data and information as 
the Director considers appropriate to demonstrate and 
assess trends relating to illicit drug use, the effects and 
consequences of illicit drug use (including the effects on 
children), supply reduction, demand reduction, drug-related
H. R. 6—244 
law enforcement, and the implementation of the National 
Drug Control Strategy. 
‘‘(M) A systematic plan for increasing data collection 
to enable real time surveillance of drug control threats, 
developing analysis and monitoring capabilities, and identi-
fying and addressing policy questions related to the 
National Drug Control Strategy and Program, which shall 
include— 
‘‘(i) a list of policy-relevant questions for which 
the Director and each National Drug Control Program 
Agency intends to develop evidence to support the 
National Drug Control Program and Strategy; 
‘‘(ii) a list of data the Director and each National 
Drug Control Program Agency intends to collect, use, 
or acquire to facilitate the use of evidence in drug 
control policymaking and monitoring; 
‘‘(iii) a list of methods and analytical approaches 
that may be used to develop evidence to support the 
National Drug Control Program and Strategy and 
related policy; 
‘‘(iv) a list of any challenges to developing evidence 
to support policymaking, including any barriers to 
accessing, collecting, or using relevant data; 
‘‘(v) a description of the steps the Director and 
the head of each National Drug Control Program 
Agency will take to effectuate the plan; and 
‘‘(vi) any other relevant information as determined 
by the Director. 
‘‘(N) A plan to expand treatment of substance use 
disorders, which shall— 
‘‘(i) identify unmet needs for treatment for sub-
stance use disorders and a strategy for closing the 
gap between available and needed treatment; 
‘‘(ii) describe the specific roles and responsibilities 
of the relevant National Drug Control Programs for 
implementing the plan; 
‘‘(iii) identify the specific resources required to 
enable the relevant National Drug Control Agencies 
to implement that strategy; and 
‘‘(iv) identify the resources, including private 
sources, required to eliminate the unmet need for evi-
dence-based substance use disorder treatment. 
‘‘(2) CONSULTATION.—In developing the plan required under 
paragraph (1), the Director shall consult with the following: 
‘‘(A) The public. 
‘‘(B) Any evaluation or analysis units and personnel 
of the Office. 
‘‘(C) Office officials responsible for implementing pri-
vacy policy. 
‘‘(D) Office officials responsible for data governance. 
‘‘(E) The appropriate congressional committees. 
‘‘(F) Any other individual or entity as determined by 
the Director. 
‘‘(3) ADDITIONAL STRATEGIES.— 
‘‘(A) IN GENERAL.—The Director shall include in the 
National Drug Control Strategy the additional strategies
H. R. 6—245 
described under this paragraph and shall comply with the 
following: 
‘‘(i) Provide a copy of the additional strategies to 
the appropriate congressional committees and to the 
Committee on Armed Services and the Committee on 
Homeland Security of the House of Representatives, 
and the Committee on Homeland Security and Govern-
mental Affairs and the Committee on Armed Services 
of the Senate. 
‘‘(ii) Issue the additional strategies in consultation 
with the head of each relevant National Drug Control 
Program Agency, any relevant official of a State, local, 
or Tribal government, and the government of other 
relevant countries. 
‘‘(iii) Not change any existing agency authority 
or construe any strategy described under this para-
graph to amend or modify any law governing inter-
agency relationship but may include recommendations 
about changes to such authority or law. 
‘‘(iv) Present separately from the rest of any 
strategy described under this paragraph any informa-
tion classified under criteria established by an Execu-
tive order, or whose public disclosure, as determined 
by the Director or the head of any relevant National 
Drug Control Program Agency, would be detrimental 
to the law enforcement or national security activities 
of any Federal, State, local, or Tribal agency. 
‘‘(B) REQUIREMENT FOR SOUTHWEST BORDER COUNTER-
NARCOTICS STRATEGY.— 
‘‘(i) PURPOSES.—The Southwest Border Counter-
narcotics Strategy shall— 
‘‘(I) set forth the Government’s strategy for 
preventing the illegal trafficking of drugs across 
the international border between the United States 
and Mexico, including through ports of entry and 
between ports of entry on that border; 
‘‘(II) state the specific roles and responsibilities 
of the relevant National Drug Control Program 
Agencies for implementing that strategy; and 
‘‘(III) identify the specific resources required 
to enable the relevant National Drug Control Pro-
gram Agencies to implement that strategy. 
‘‘(ii) SPECIFIC CONTENT RELATED TO DRUG TUNNELS 
BETWEEN THE UNITED STATES AND MEXICO.—The South-
west Border Counternarcotics Strategy shall include— 
‘‘(I) a strategy to end the construction and 
use of tunnels and subterranean passages that 
cross the international border between the United 
States and Mexico for the purpose of illegal traf-
ficking of drugs across such border; and 
‘‘(II) recommendations for criminal penalties 
for persons who construct or use such a tunnel 
or subterranean passage for such a purpose. 
‘‘(C) REQUIREMENT FOR NORTHERN BORDER COUNTER-
NARCOTICS STRATEGY.— 
‘‘(i) PURPOSES.—The Northern Border Counter-
narcotics Strategy shall—
H. R. 6—246 
‘‘(I) set forth the strategy of the Federal 
Government for preventing the illegal trafficking 
of drugs across the international border between 
the United States and Canada, including through 
ports of entry and between ports of entry on the 
border; 
‘‘(II) state the specific roles and responsibilities 
of each relevant National Drug Control Program 
Agency for implementing the strategy; 
‘‘(III) identify the specific resources required 
to enable the relevant National Drug Control Pro-
gram Agencies to implement the strategy; 
‘‘(IV) be designed to promote, and not hinder, 
legitimate trade and travel; and 
‘‘(V) reflect the unique nature of small commu-
nities along the international border between the 
United States and Canada, ongoing cooperation 
and coordination with Canadian law, enforcement 
authorities, and variations in the volumes of 
vehicles and pedestrians crossing through ports 
of entry along the international border between 
the United States and Canada. 
‘‘(ii) SPECIFIC CONTENT RELATED TO CROSS-BORDER 
INDIAN RESERVATIONS.—The Northern Border Counter-
narcotics Strategy shall include— 
‘‘(I) a strategy to end the illegal trafficking 
of drugs to or through Indian reservations on or 
near the international border between the United 
States and Canada; and 
‘‘(II) recommendations for additional assist-
ance, if any, needed by Tribal law enforcement 
agencies relating to the strategy, including an 
evaluation of Federal technical and financial 
assistance, infrastructure capacity building, and 
interoperability deficiencies. 
‘‘(4) CLASSIFIED
INFORMATION.—Any contents of the 
National Drug Control Strategy that involve information prop-
erly classified under criteria established by an Executive order 
shall be presented to Congress separately from the rest of 
the National Drug Control Strategy. 
‘‘(5) SELECTION OF DATA AND INFORMATION.—In selecting 
data and information for inclusion in the Strategy, the Director 
shall ensure— 
‘‘(A) the inclusion of data and information that will 
permit analysis of current trends against previously com-
piled data and information where the Director believes 
such analysis enhances long-term assessment of the 
National Drug Control Strategy; and 
‘‘(B) the inclusion of data and information to permit 
a standardized and uniform assessment of the effectiveness 
of drug treatment programs in the United States. 
‘‘(d) SUBMISSION OF REVISED STRATEGY.—The President may 
submit to Congress a revised National Drug Control Strategy that 
meets the requirements of this section— 
‘‘(1) at any time, upon a determination of the President, 
in consultation with the Director, that the National Drug Con-
trol Strategy in effect is not sufficiently effective; or
H. R. 6—247 
‘‘(2) if a new President or Director takes office. 
‘‘(e) FAILURE OF DIRECTOR TO SUBMIT NATIONAL DRUG CONTROL 
STRATEGY.—If the Director does not submit a National Drug Control 
Strategy to Congress in accordance with subsection (a)(2), not later 
than five days after the first Monday in February following the 
year in which the term of the President commences, the Director 
shall send a notification to the appropriate congressional commit-
tees— 
‘‘(1) explaining why the Strategy was not submitted; and 
‘‘(2) specifying the date by which the Strategy will be 
submitted. 
‘‘(f) DRUG CONTROL DATA DASHBOARD.— 
‘‘(1) IN GENERAL.—The Director shall collect and dissemi-
nate, as appropriate, such information as the Director deter-
mines is appropriate, but not less than the information 
described in this subsection. The data shall be publicly available 
in a machine-readable format on the online portal of the Office, 
and to the extent practicable on the Drug Control Data Dash-
board. 
‘‘(2) ESTABLISHMENT.—The Director shall publish to the 
online portal of the office in a machine-readable, sortable, and 
searchable format, or to the extent practicable, establish and 
maintain a data dashboard on the online portal of the Office 
to be known as the ‘Drug Control Data Dashboard’. To the 
extent practicable, when establishing the Drug Control Dash-
board, the Director shall ensure the user interface of the dash-
board is constructed with modern design standards. To the 
extent practicable, the data made available on the dashboard 
shall be publicly available in a machine-readable format and 
searchable by year, agency, drug, and location. 
‘‘(3) DATA.—The data included in the Drug Control Data 
Dashboard shall be updated quarterly to the extent practicable, 
but not less frequently than annually and shall include, at 
a minimum, the following: 
‘‘(A) For each substance identified by the Director as 
having a significant impact on the prevalence of illicit 
drug use— 
‘‘(i) data sufficient to show the quantities of such 
substance available in the United States, including— 
‘‘(I) the total amount seized and disrupted in 
the calendar year and each of the previous 3 cal-
endar years, including to the extent practicable 
the amount seized by State, local, and Tribal 
governments; 
‘‘(II) the known and estimated flows into the 
United States from all sources in the calendar 
year and each of the previous 3 calendar years; 
‘‘(III) the total amount of known flows that 
could not be interdicted or disrupted in the cal-
endar year and each of the previous 3 calendar 
years; 
‘‘(IV) the known and estimated levels of 
domestic production in the calendar year and each 
of the previous three calendar years, including the 
levels of domestic production if the drug is a 
prescription drug, as determined under the Federal 
Food, Drug, and Cosmetic Act, for which a listing
H. R. 6—248 
is in effect under section 202 of the Controlled 
Substances Act (21 U.S.C. 812); 
‘‘(V) the average street price for the calendar 
year and the highest known street price during 
the preceding 10-year period; and 
‘‘(VI) to the extent practicable, related prosecu-
tions by State, local, and Tribal governments; 
‘‘(ii) data sufficient to show the frequency of use 
of such substance, including— 
‘‘(I) use of such substance in the workplace 
and productivity lost by such use; 
‘‘(II) use of such substance by arrestees, proba-
tioners, and parolees; 
‘‘(III) crime and criminal activity related to 
such substance; 
‘‘(IV) to the extent practicable, related prosecu-
tions by State, local, and Tribal governments; 
‘‘(B) For the calendar year and each of the previous 
three years data sufficient to show, disaggregated by State 
and, to the extent feasible, by region within a State, county, 
or city, the following: 
‘‘(i) The number of fatal and non-fatal overdoses 
caused by each drug identified under subparagraph 
(A)(i). 
‘‘(ii) The prevalence of substance use disorders. 
‘‘(iii) The number of individuals who have received 
substance use disorder treatment, including medication 
assisted treatment, for a substance use disorder, 
including treatment provided through publicly-financed 
health care programs. 
‘‘(iv) The extent of the unmet need for substance 
use disorder treatment, including the unmet need for 
medication-assisted treatment. 
‘‘(C) Data sufficient to show the extent of prescription 
drug diversion, trafficking, and misuse in the calendar 
year and each of the previous 3 calendar years. 
‘‘(D) Any quantifiable measures the Director deter-
mines to be appropriate to detail progress toward the 
achievement of the goals of the National Drug Control 
Strategy. 
‘‘(g) DEVELOPMENT OF AN ANNUAL NATIONAL DRUG CONTROL 
ASSESSMENT.— 
‘‘(1) TIMING.—Not later than the first Monday in February 
of each year, the Director shall submit to the President, Con-
gress, and the appropriate congressional committees, a report 
assessing the progress of each National Drug Control Program 
Agency toward achieving each goal, objective, and target con-
tained in the National Drug Control Strategy applicable to 
the prior fiscal year. 
‘‘(2) PROCESS FOR DEVELOPMENT OF THE ANNUAL ASSESS-
MENT.—Not later than November 1 of each year, the head 
of each National Drug Control Program Agency shall submit, 
in accordance with guidance issued by the Director, to the 
Director an evaluation of progress by the agency with respect 
to the National Drug Control Strategy goals using the perform-
ance measures for the agency developed under this title, 
including progress with respect to—
H. R. 6—249 
‘‘(A) success in achieving the goals of the National 
Drug Control Strategy; 
‘‘(B) success in reducing domestic and foreign sources 
of illegal drugs; 
‘‘(C) success in expanding access to and increasing 
the effectiveness of substance use disorder treatment; 
‘‘(D) success in protecting the borders of the United 
States (and in particular the Southwestern border of the 
United States) from penetration by illegal narcotics; 
‘‘(E) success in reducing crime associated with drug 
use in the United States; 
‘‘(F) success in reducing the negative health and social 
consequences of drug use in the United States; 
‘‘(G) implementation of evidence-based substance use 
disorder treatment and prevention programs in the United 
States and improvements in the adequacy and effectiveness 
of such programs; and 
‘‘(H) success in increasing the prevention of illicit drug 
use. 
‘‘(3) CONTENTS OF THE ANNUAL ASSESSMENT.—The Director 
shall include in the annual assessment required under para-
graph (1)— 
‘‘(A) a summary of each evaluation received by the 
Director under paragraph (2); 
‘‘(B) a summary of the progress of each National Drug 
Control Program Agency toward the National Drug Control 
Strategy goals of the agency using the performance meas-
ures for the agency developed under this chapter; 
‘‘(C) an assessment of the effectiveness of each National 
Drug Control Program Agency and program in achieving 
the National Drug Control Strategy for the previous year, 
including a specific evaluation of whether the applicable 
goals, measures, objectives, and targets for the previous 
year were met; and 
‘‘(D) the assessments required under this subsection 
shall be based on the Performance Measurement System.’’. 
(b) TECHNICAL AND CONFORMING AMENDMENTS.— 
(1) Section 704(b) of the Office of National Drug Control 
Policy Reauthorization Act of 1998 (21 U.S.C. 1703(b)) is 
amended— 
(A) by striking paragraphs (13) and (17); and 
(B) in paragraph (14)(A), by striking ‘‘paragraph (13)’’ 
and inserting ‘‘section 706(g)(2)’’. 
(2) The Office of National Drug Control Policy Reauthoriza-
tion Act of 2006 (Public Law 109–469; 120 Stat. 3502) is 
amended by striking sections 1110 and 1110A. 
SEC. 8222. TECHNICAL AND CONFORMING AMENDMENTS TO THE 
OFFICE 
OF 
NATIONAL 
DRUG 
CONTROL 
POLICY 
REAUTHORIZATION ACT OF 1998. 
The Office of National Drug Control Policy Reauthorization 
Act of 1998 (21 U.S.C. 1701 et seq.) is amended— 
(1) by striking section 703(b) (21 U.S.C. 1702(b)); 
(2) in section 704 (21 U.S.C. 1703)— 
(A) in subsection (c)— 
(i) in paragraph (3)(C)—
H. R. 6—250 
(I) in the matter before clause (i), by inserting 
‘‘requests a level of funding that will not enable 
achievement of the goals of the National Drug 
Control Strategy, including’’ after ‘‘request that’’; 
(II) in clause (iii)— 
(aa) by striking ‘‘drug treatment’’ and 
inserting ‘‘substance use disorder prevention 
and treatment’’; and 
(bb) by striking the semicolon at the end 
and inserting ‘‘; and’’; 
(III) by striking clauses (iv), (vi), and (vii); 
(IV) by redesignating clause (v) as clause (iv); 
and 
(V) in clause (iv), as so redesignated, by 
striking the semicolon and inserting a period; 
(ii) in paragraph (4)(A), by striking ‘‘$1,000,000’’ 
and inserting ‘‘$5,000,000 or 10 percent of a specific 
program or account’’; and 
(B) in subsection (f)— 
(i) by striking the first paragraph (5); and 
(ii) by striking the second paragraph (4); and 
(3) by striking section 708 (21 U.S.C. 1707). 
Subtitle L—Budgetary Effects 
SEC. 8231. BUDGETARY EFFECT. 
(a) IN GENERAL.—The budgetary effects of this Act shall not 
be entered on either PAYGO scorecard maintained pursuant to 
section 4(d) of the Statutory Pay-As-You-Go Act of 2010 (2 U.S.C. 
933(d)). 
(b) SENATE PAYGO SCORECARDS.—The budgetary effects of this 
Act shall not be entered on any PAYGO scorecard maintained 
for purposes of section 4106 of H. Con. Res. 71 (115th Congress). 
Speaker of the House of Representatives. 
Vice President of the United States and
President of the Senate.